Company News

Redefining WCDs, a conversation with Kestra’s CEO Brian Webster

Sudden Cardiac Arrest (SCA) is a life-threatening condition affecting hundreds of thousands of individuals each year, particularly those with low Left Ventricular Ejection Fraction (LVEF). While wearable cardioverter defibrillators (WCDs) are a well-established therapy for preventing SCA, adherence rates are often low. Kestra Medical Technologies is tackling this issue [...]

2025-01-17T16:50:01+00:00January 17th, 2025|All News, Blog, Company News, Investment, Medtech|

From investment to acquisition: Gynesonics’ journey in transforming women’s health Q&A with Endeavour Vision’s Partner, Alexander Schmitz

First backed by Endeavour Vision in 2015, Gynesonics is a women’s healthcare company focused on improving the treatment of uterine fibroids through its innovative Sonata® System. This minimally invasive technology provides a uterine-preserving option for symptomatic fibroids that offers women a faster, safer alternative to traditional surgical procedures. Hologic [...]

2025-01-17T15:41:19+00:00January 17th, 2025|All News, Blog, Company News|

Hologic Completes Acquisition of Gynesonics, Inc

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health, for approximately $350 million. “We are excited to complete [...]

2025-01-06T23:43:47+00:00January 6th, 2025|All News, Company News|

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health

MARLBOROUGH, Mass. 14 October--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health for approximately $350 [...]

2024-10-15T07:16:02+01:00October 15th, 2024|All News, Company News|

Johnson & Johnson to Acquire V-Wave

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. Under the terms of the agreement, Johnson & Johnson will acquire V-Wave for [...]

2024-08-20T16:07:22+01:00August 20th, 2024|All News, Company News, Investment|

Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon

SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"  Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. [...]

2024-08-12T21:21:27+01:00August 12th, 2024|All News, Company News, Investment, Medtech|

Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round

KIRKLAND, Wash. July 24, 2024 08:00 AM Eastern Daylight--(BUSINESS WIRE)-- Kestra Medical Technologies, Inc., a privately held wearable medical device and digital healthcare company, today announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with [...]

2024-07-29T17:05:17+01:00July 29th, 2024|All News, Company News, Investment, Medtech|

IntelyCare Appoints Industry Leader Matthew Levesque as CEO

QUINCY, Mass. July 10, 2024. IntelyCare, the healthcare industry’s most comprehensive nurse talent platform, today announced that it has appointed Matthew Levesque as the new Chief Executive Officer and member of the Board of Directors. A veteran healthcare executive known for scaling mission-driven organizations, Levesque will lead the expansion [...]

2024-07-18T21:03:23+01:00July 18th, 2024|All News, Company News|

Matthias Schupp appointed as CEO of Medartis

Basel, 9th July 2024. Medartis today announced that its Board has appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. Matthias will succeed Christoph Brönnimann, who will ensure a seamless transition. Matthias brings excellent knowledge of the global medical technology sector, having held [...]

2024-07-09T09:26:33+01:00July 9th, 2024|All News, Company News|

CeQur Simplicity™, a Wearable Mealtime Insulin Delivery Device, Obtains FDA-Clearance for 4 Days of Wear to Further Simplify Diabetes Management

The CeQur Simplicity patch is now FDA-cleared for up to 4 days of wear. Each patch replaces up to 12 injections further simplifying mealtime insulin management. Horw, Switzerland, June 18, 2024 - CeQur®, a medical device company dedicated to simplifying insulin delivery for individuals on multiple daily injections, announces [...]

2024-06-20T20:45:44+01:00June 20th, 2024|All News, Company News, Investment, Medtech|
Go to Top